The interconnectedness of the brain, body and lifestyle factors and how they collectively influence mental health has been demonstrated by new research.
Aug 9, 2024
0
41
An AI model developed by Northwestern Medicine investigators improved the transformation of EHR data into standardized health resources more efficiently than current methods, according to a recent study published in the journal ...
Aug 8, 2024
0
0
Some artificial intelligence tools for health care may get confused by the ways people of different genders and races talk, according to a new study led by CU Boulder computer scientist Theodora Chaspari.
Aug 5, 2024
0
21
Researchers at Osaka University identified problems in access and use of oral contraceptives among transnational Japanese patients created by different perceptions from physicians. The findings revealed the clinical and ethical ...
Aug 5, 2024
0
0
Mental health screenings must be incorporated into routine prostate cancer diagnoses say University of South Australia researchers. The call follows new research in Psycho-Oncology that shows men need more support both during ...
Aug 5, 2024
0
0
A new form of immunotherapy using innovative nanoparticles can delay resistance to hormone therapy and help men with prostate cancer live longer.
Aug 5, 2024
0
1
Montana is proposing wide-ranging rules for licensing abortion clinics under a disputed state law, raising a new potential obstacle for patients even as a constitutional amendment to protect access appears headed for the ...
Aug 5, 2024
0
0
Wearable trackers and monitors (such as smartwatches) are increasingly popular and sophisticated. For people living with heart conditions, they can provide important information, including updates about abnormalities in heart ...
Aug 4, 2024
0
19
The Australian National Health and Medical Research Council (NHMRC) has just released its much-anticipated landmark statement advocating for sex, gender, variations of sex characteristics and sexual orientation to be routinely ...
Aug 4, 2024
0
0
A research group led by Kyoto University has produced the world's first pluripotent stem cell-derived killer T-cell drug to treat COVID-19. The University has filed a patent application ahead of full-scale drug development.
Aug 2, 2024
0
28
